About me
Scott McConnell, Pharm.D. is currently the VP of Clinical Sciences and Pharmacovigilance at Xilio Therapeutics. He has spent the last 19 years in various roles within Medical Affairs at Cubist, Merck, Chiasma (Amryt), Alkermes and Venatorx. Prior to industry he spent several years in both academic and clinical pharmacy positions and has completed a post-doctoral residency and fellowship.